Brief: Prime Medicine, Inc. Q1 EPS USD -0.28
07/05/2026 13:00
May 07 (Reuters) - Prime Medicine, Inc. Q1 operating expenses USD 51.51 million. Q1 income from operations USD -50.654 million Q1 net income USD -49.122 million
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease